Clinical validation of Ki67 by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in HR+/HER2- early breast cancer

Objective: To evaluate the clinical value of Ki67 by RT-PCR, we investigated the concordance of Ki67 expression by IHC and by RT-PCR, and assessed their prognostic value in HR+/HER2- early breast cancer. Methods: 1259 HR+/HER2- early breast cancer patients treated at Ruijin Hospital with recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Weiqi, Wu, Jiayi, Chen, Xiaosong, Lin, Lin, Fei, Xiaochun, Shen, Kunwei, Huang, Ou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400683/
https://www.ncbi.nlm.nih.gov/pubmed/30854118
http://dx.doi.org/10.7150/jca.29337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400683/
https://www.ncbi.nlm.nih.gov/pubmed/30854118
http://dx.doi.org/10.7150/jca.29337

Ejemplares similares